NP / PA
England, Russell
England, Russell was paid $175K by Medicaid between Mar 2019 and Mar 2023, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoENGLAND, RUSSELL
GLASGOW, KY 42141
GLASGOW, KY 42141
33aNPI1821413022assigned 02/25/2014
33bProvider typeNurse Practitioner
28Total paid$175K
24GClaims6,922
24DCodes billed14
24AFirst – last monthMar 2019 – Mar 2023
Compared with peers
Next to other Nurse Practitioner providers in Kentucky
Rank by total paid#101 of 260
Median peer was paid$89K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,160 | $53K | |
| 2020 | 2,246 | $57K | |
| 2021 | 339 | $9K | |
| 2022 | 1,933 | $50K | |
| 2023 | 244 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 3,078 | 2,385 | $87K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 724 | 641 | $29K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 494 | 442 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.1% | 619 | 340 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.5% | 659 | 591 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.3% | 558 | 444 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3.1% | 110 | 105 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 172 | 169 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 418 | 391 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 15 | 15 | $596.25 |
| 80305 | <1% | 12 | 12 | $129.15 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | 12 | $117.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.